* Apollo Medical Holdings Inc AMEH.OQ AMEH.O is expected to
show a rise in quarterly revenue when it reports results on May
5.
* The Alhambra, California-based company is expected to report
a 4.0% increase in revenue to $171.736 million from $165.11
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Apollo Medical Holdings
Inc is for earnings of 22 cents per share. For the same quarter
last year, the company reported earnings of 11 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Apollo Medical
Holdings Inc is $32, about 3.7% above its last closing price
of $30.81.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 0.18 0.18 0.27 Beat 50
Sep. 30 2020 0.22 0.22 0.45 Beat 104.5
Jun. 30 2020 0.07 0.07 -1.75 Missed -2,600
Mar. 31 2020 0.04 0.04 0.11 Beat 175
Dec. 0.20 0.18 Missed -10
31 2019
Sep. 30 2019 0.14 0.14 0.10 Missed -28.6
Jun. 30 2019 0.05 0.09 Beat 80
Mar. 31 2019 0.08 0.08 0.00 Missed -100
This summary was machine generated May 3 at 23:15 GMT. All
figures in US dollars unless otherwise stated